CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (CERA) PROMOTES IRON UTILIZATION FOR ERYTHROPOIESIS THROUGH INTENSIVE SUPPRESSION OF HEPCIDIN LEVELS IN MICE

被引：0
|
作者：
Sasaki, Yusuke [1 ]
Matsumoto-Omori, Yuki [1 ]
Noguchi-Sasaki, Mariko [1 ]
Kurasawa, Mitsue [1 ]
Yorozu, Keigo [1 ]
Shimonaka, Yasushi [1 ]
Ikuta, Katsuya [2 ]
Kohgo, Yutaka [2 ]
机构：
[1] Chugai Pharmaceut Co Ltd, Tokyo, Japan
[2] Asahikawa Med Coll, Asahikawa, Hokkaido 078, Japan
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2013年 / 88卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E89 / E90
页数：2
相关论文
共 16 条
  • [1] CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (CERA) PROMOTES IRON RECRUITMENT FROM RETICULOENDOTHELIAL CELLS THROUGH INTENSIVE SUPPRESSION OF HEPCIDIN LEVELS IN MICE
    Shimonaka, Yasushi
    Sasaki, Yusuke
    Yorozu, Keigo
    Sasaki, Mariko Noguchi
    Ikuta, Katsuya
    Kohgo, Yutaka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 240 - 241
  • [2] Epoetin beta pegol (CERA) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice
    Sasaki, Yusuke
    Noguchi-Sasaki, Mariko
    Matsuo-Tezuka, Yukari
    Matsumoto-Omori, Yuki
    Kurasawa, Mitsue
    Yorozu, Keigo
    Shimonaka, Yasushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 561 - 569
  • [3] EPOETIN BETA PEGOL PROMOTES IRON UTILIZATION FOR ERYTHROPOIESIS THROUGH INTENSIVE SUPPRESSION OF SERUM HEPCIDIN LEVELS IN INHERITED SUPER-ANAEMIC MICE
    Sasaki, Yusuke
    Yamazaki, Shun
    Fujita, Ken
    Kurasawa, Mitsue
    Yorozu, Keigo
    Shimonaka, Yasushi
    Suzuki, Norio
    Yamamoto, Masayuki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 495 - 496
  • [4] Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice
    Yusuke Sasaki
    Mariko Noguchi-Sasaki
    Yukari Matsuo-Tezuka
    Yuki Matsumoto-Omori
    Mitsue Kurasawa
    Keigo Yorozu
    Yasushi Shimonaka
    International Journal of Hematology, 2014, 99 : 561 - 569
  • [5] REPEATED ADMINISTRATION OF CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (CERA) REPRODUCES SINGLE ADMINISTRATION IN TERMS OF ACTIVATION OF HEMATOPOIESIS AND IRON MOBILIZATION IN MICE
    Matsuo, Yukari
    Sasaki, Yusuke
    Omori, Yuki
    Yorozu, Keigo
    Shimonaka, Yasushi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 241 - 241
  • [6] IRON DYNAMICS IN HEMODIALYSIS PATIENTS RECEIVING EPOETIN-BETA OR CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (CERA)
    Horie, Masanobu
    Hasegawa, Eizou
    Minoshima, Ken-ichi
    Shimonaka, Yasushi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 242 - 242
  • [7] Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients
    Shoji, Shigeichi
    Inaba, Masaaki
    Tomosugi, Naohisa
    Okuno, Senji
    Ichii, Mitsuru
    Yamakawa, Tomoyuki
    Kurihara, Satoshi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (03) : 237 - 244
  • [8] Adequate hemoglobin levels are maintained with continuous erythropoietin receptor activator (CERA) in dialysis patients with different ranges of iron status and pre-existing conditions
    Salifu, M
    Villa, G
    Doughtery, FC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A53 - A53
  • [9] CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR (CERA) DELAYS PROGRESSION OF KIDNEY DISEASE DUE TO EARLY SUPPRESSION OF GLOMERULOSCLEROSIS IN RATS WITH PROGRESSIVE GLOMERULONEPHRITIS
    Hirata, Michinori
    Tashiro, Yoshihito
    Aizawa, Ken
    Endo, Koichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 358 - 358
  • [10] Adequate hemoglobin levels are maintained with continuous erythropoietin receptor activator (CERA) in dialysis patients regardless of gender, age, race, and diabetic status
    Dougherty, FC
    Loghman-Adham, M
    Schultze, N
    Beyer, U
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V269 - V269
12